Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
27.94
+1.00 (3.71%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Dianthus Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for DNTH stock have an average target of 45.14, with a low estimate of 36 and a high estimate of 58. The average target predicts an increase of 61.56% from the current stock price of 27.94.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DNTH stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 3 | 4 | 4 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $48 | Buy | Initiates | $48 | +71.80% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +43.16% | Sep 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +43.16% | Aug 12, 2024 |
| Wedbush | Wedbush | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +28.85% | Aug 9, 2024 |
| Baird | Baird | Buy Initiates $58 | Buy | Initiates | $58 | +107.59% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
4.00M
from 2.83M
Increased by 41.61%
Revenue Next Year
2.64M
from 4.00M
Decreased by -34.11%
EPS This Year
-2.28
from -8.45
EPS Next Year
-2.80
from -2.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.8M | 7.8M | 7.8M |
| Avg | 4.0M | 2.6M | 3.2M |
| Low | 2.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 140.1% | 95.5% | 196.7% |
| Avg | 41.6% | -34.1% | 19.9% |
| Low | -6.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.88 | -2.43 | -2.34 |
| Avg | -2.28 | -2.80 | -3.42 |
| Low | -2.53 | -3.29 | -4.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.